FORM DEF 14A

Company

UroGen Pharma Ltd.

Filed

August 1, 2023

Period of Report

September 7, 2023

Accession Number

0001437749-23-021412

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →